Clinical trial
Indicated Prevention With Omega-3 Fatty Acids in Adolescents With…
NCT00396643 · Medical University of Vienna, Other · Completed
Key facts
| NCT number | NCT00396643 |
|---|---|
| Title | Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis |
| Official title | Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis: A Randomised, Double Blind, Placebo-Controlled Treatment Trial |
| Lead sponsor | Medical University of Vienna, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Prodrome |
| Intervention type | Drug |
| Interventions | Omega 3 fatty acids |
| Enrollment | 81 |
| Start date | May 1, 2004 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Nov 7, 2006 |
| Last update posted | Dec 27, 2007 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: